Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darren Magda

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Nuclear Medicine and Biology|December 10, 2025
Matched pair suitability of <sup>89</sup>Zr and <sup>177</sup>Lu-labeled L804-LLP2A theranostics for targeting VLA-4 in melanomaCyril O Y Fong, Ejike V Iweha, Fabio Gallazzi, et al.
Molecular Cancer Therapeutics|June 16, 2005
Sapphyrins induce apoptosis in hematopoietic tumor-derived cell lines and show in vivo antitumor activityLouie Naumovski, Jason Ramos, Mint Sirisawad, et al.
Theranostics|March 5, 2016
Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in MiceJeff N Tinianow, Darpan N Pandya, Sylvie L Pailloux, et al.
Cancer Research|July 3, 2008
Synthesis and anticancer properties of water-soluble zinc ionophoresDarren Magda, Philip Lecane, Zhong Wang, et al.
Cancer Research|May 4, 2005
Motexafin gadolinium disrupts zinc metabolism in human cancer cell linesDarren Magda, Philip Lecane, Richard A Miller, et al.
Molecular Cancer Therapeutics|November 24, 2006
Tumor localization and antitumor efficacy of novel sapphyrin compoundsLouie Naumovski, Mint Sirisawad, Philip Lecane, et al.
Molecular Cancer|January 20, 2007
Synthesis and biologic properties of hydrophilic sapphyrins, a new class of tumor-selective inhibitors of gene expressionZhong Wang, Philip S Lecane, Patricia Thiemann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2023
Evaluation of Candidate Theranostics for <sup>227</sup>Th/<sup>89</sup>Zr Paired Radioimmunotherapy of LymphomaDiane S Abou, Mark Longtine, Amanda Fears, et al.
Ebiomedicine|September 16, 2021
Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in gliomaAlexandra Foster, Shubhanchi Nigam, David S Tatum, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Nuclear Medicine and Biology|December 10, 2025
Matched pair suitability of <sup>89</sup>Zr and <sup>177</sup>Lu-labeled L804-LLP2A theranostics for targeting VLA-4 in melanomaCyril O Y Fong, Ejike V Iweha, Fabio Gallazzi, et al.
Molecular Cancer Therapeutics|June 16, 2005
Sapphyrins induce apoptosis in hematopoietic tumor-derived cell lines and show in vivo antitumor activityLouie Naumovski, Jason Ramos, Mint Sirisawad, et al.
Theranostics|March 5, 2016
Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in MiceJeff N Tinianow, Darpan N Pandya, Sylvie L Pailloux, et al.
Cancer Research|July 3, 2008
Synthesis and anticancer properties of water-soluble zinc ionophoresDarren Magda, Philip Lecane, Zhong Wang, et al.
Cancer Research|May 4, 2005
Motexafin gadolinium disrupts zinc metabolism in human cancer cell linesDarren Magda, Philip Lecane, Richard A Miller, et al.
Molecular Cancer Therapeutics|November 24, 2006
Tumor localization and antitumor efficacy of novel sapphyrin compoundsLouie Naumovski, Mint Sirisawad, Philip Lecane, et al.
Molecular Cancer|January 20, 2007
Synthesis and biologic properties of hydrophilic sapphyrins, a new class of tumor-selective inhibitors of gene expressionZhong Wang, Philip S Lecane, Patricia Thiemann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 4, 2023
Evaluation of Candidate Theranostics for <sup>227</sup>Th/<sup>89</sup>Zr Paired Radioimmunotherapy of LymphomaDiane S Abou, Mark Longtine, Amanda Fears, et al.
Ebiomedicine|September 16, 2021
Novel theranostic agent for PET imaging and targeted radiopharmaceutical therapy of tumour-infiltrating immune cells in gliomaAlexandra Foster, Shubhanchi Nigam, David S Tatum, et al.
Pageof 3